While sex is commonly disclosed in interstitial lung disease trials, data on participant race and ethnicity are infrequently documented.

Patients with rheumatoid arthritis (RA) face increased risk for interstitial lung disease (ILD) and comorbidities appear to raise it further. This retrospective study sought to compare different ...

Patients with interstitial lung disease who are positive for anti-Ku antibody may show progressive fibrotic behavior.

Please provide your email address to receive an email when new articles are posted on . Eight clusters of related biomarkers were significantly associated with RA-ILD. The biomarkers led to a greater ...

AI-based deep learning models can detect interstitial lung disease from lung ultrasound images in patients with systemic ...

Rural ILD patients experience significant diagnostic and treatment delays compared to urban counterparts, highlighting access challenges. Telehealth shows promise in improving access to ILD care, ...

Please provide your email address to receive an email when new articles are posted on . A CHEST project hopes to educate health care workers on best practices in interstitial lung disease diagnosis.

Pulmonary arterial hypertension (PAH) and interstitial lung disease (ILD) are the leading causes of systemic sclerosis (SSc)-associated death, and there's increasing interest in patients with the ...

Patients with rheumatoid arthritis (RA) treated with tofacitinib (Xeljanz) were 69% less likely to develop interstitial lung disease (ILD), compared with those treated with adalimumab (Humira), ...

Neil B. Minkoff, MD: Dr Hummers, please share the prevalence of chronic fibrosis ILD [interstitial lung disease] with the progressive phenotype? Laura Hummers, MD: It’s tricky to determine a phenotype ...

Diffuse parenchymal lung diseases encompass a large number of conditions, with a wide range of causes, clinical manifestations, and imaging and pathological features, as well as variable outcomes.